Market Place
Sourcing Support
CapVest Completes Majority Acquisition of Stada
31 Mar 2026 //
BUSINESSWIRE
Calliditas to Present Biomarker & Post-Hoc NefIgArd Analyses
30 Mar 2026 //
PR NEWSWIRE
CuraTeQ Bio Enters Into Agreement with Stada Arzneimittel AG
27 Mar 2026 //
INDPHARMAPOST
Stada Sets Sights On €85M Saudi Arabia Manufacturing Hub
17 Feb 2026 //
FIERCE PHARMA
CapVest to Acquire Majority Stake in STADA from Bain Capital
01 Sep 2025 //
BUSINESSWIRE
CapVest Is in Talks for Drugmaker Stada in €10 Billion Deal
23 Jul 2025 //
BLOOMBERG
Stada in Talks with Private Equity Groups for Sale
03 Jun 2025 //
REUTERS
Putin picks firm to manage pharma spinoff from Stada
04 Apr 2025 //
REUTERS
Stada reschedules IPO due to market volatility, sources say
18 Mar 2025 //
REUTERS
Stada Reports Strong Earnings, CEO Tempers Sale And IPO Expectations
28 Aug 2024 //
FIERCE PHARMA
Alvotech and STADA add to strategic alliance through denosumab partnership
12 Jun 2024 //
PRESS RELEASE
Calliditas Partner STADA Gets CHMP Nod For Kinpeygo In IgA Nephropathy
31 May 2024 //
PR NEWSWIRE
Germany`s Stada has spun off Russian business - newspaper
23 Dec 2023 //
REUTERS
STADA & Calliditas announce filing for full marketing authorization of Kinpeygo
28 Sep 2023 //
PR NEWSWIRE
Stada in `exploratory` phase of potential sale: CEO
15 Aug 2023 //
FIERCE PHARMA
Advent, CVC Are Among Suitors for €3 Billion Viatris OTC Assets
10 Feb 2023 //
BLOOMBERG
Stada appoints Boris Döbler as chief financial officer
03 Jan 2023 //
PHARMABIZ
With boost from Romania, Stada breaks ground on $50M plant
28 Nov 2022 //
FIERCEPHARMA
Stada to place $50M+ investment in a new facility in Romania
28 Nov 2022 //
ENDPTS
Stada and Xbrane gain EU approval for biosimilar Ximluci
11 Nov 2022 //
PHARMATIMES
Alvotech, Stada introduce Hukyndra, a biosimilar to adalimumab in Switzerland
23 Sep 2022 //
PHARMABIZ
Alvotech and STADA Increase Access to Adalimumab for Patients in Switzerland
22 Sep 2022 //
GLOBENEWSWIRE
Stada introduces Kinpeygo in European markets to treat primary IgA nephropathy
21 Sep 2022 //
PHARMABIZ
Calliditas` partner STADA launches the first medicine authorized in the EU
20 Sep 2022 //
PRNEWSWIRE
STADA and Xbrane welcome EMA positive opinion for ranibizumab biosimilar
16 Sep 2022 //
STADA
STADA and Alvotech broaden European patients’ options by launching Hukyndra
09 Jun 2022 //
BUSINESSWIRE
Teva launches Revlimid generic, the first to do so in U.S.
08 Mar 2022 //
FIERCEPHARMA
Sandoz launches generic oncology treatment in Europe
19 Feb 2022 //
PMLIVE
Crescita Therapeutics and STADA Enter Exclusive Licensing Agreement for Pliaglis
18 Aug 2021 //
BUSINESSWIRE
STADA & Sanofi strike consumer healthcare distribution agreement in EU
27 Jul 2021 //
PRESSEPORTAL
STADA & Sanofi strike consumer healthcare distribution agreement in EU
27 Jul 2021 //
PRESSEPORTAL
STADA and PharmaMar sign agreement to commercialize Yondelis®
17 Nov 2020 //
ZAWYA
European Company STADA enters exclusive Medical Partnership MediPharm Labs
05 Oct 2020 //
STADA
STADA expands specialty footprint through acquisition of innovative therapy
03 Oct 2020 //
PRESSRELEASE
STADA expands specialty footprint through acquisition of innovative therapy
02 Oct 2020 //
PRESS RELEASE
STADA‘s US partner Supernus submits NDA for apomorphine infusion pump
15 Sep 2020 //
PRESS RELEASE
